|
Dr. Fass has 35 years of senior pharmaceutical management experience. He retired from Savient Pharmaceuticals (SVNT; formerly Bio-Technology General Corp) after a 21 year tenure in which he served as CEO and Chairman from 1997-2004; President and CEO from 1984-1997; and COO from 1983-1984. Savient develops and commercializes specialty pharmaceuticals some of which are genetically engineered. Under Dr. Fass’ leadership Savient achieved revenues in excess of $100 million in 2004. From 1980-1983 Dr. Fass was Vice President and General Manager of Wampole Laboratories a division of Carter Wallace focusing on diagnostics of infectious diseases immune-related disorders and reproduction. From 1969-1980 he held a number of marketing sales and senior management positions at Pfizer Inc in both pharmaceuticals and diagnostics. He received a BS degree in biology and chemistry from Yeshiva College and a doctoral degree in developmental biology/biochemistry from the Massachusetts Institute of Technology. | 